HP
22
-4
HPQ
67
-2
ICE
64
-2
AES
45
-4
GOOG
67
10
AMG
54
-4
OXY
45
-3
EFX
74
-3
SIG
37
5
SLB
35
-3
SJM
29
5
XYL
66
-4
HD
55
-3
BXP
50
-2
GOOGL
45
-2
STI
16
3
PG
68
4
ADM
44
2
MRK
43
2
MCK
78
-2
HP
22
-4
HPQ
67
-2
ICE
64
-2
AES
45
-4
GOOG
67
10
AMG
54
-4
OXY
45
-3
EFX
74
-3
SIG
37
5
SLB
35
-3
SJM
29
5
XYL
66
-4
HD
55
-3
BXP
50
-2
GOOGL
45
-2
STI
16
3
PG
68
4
ADM
44
2
MRK
43
2
MCK
78
-2
Financhill
Back

AstraZeneca PLC 10K Form

Buy
54

AZN
AstraZeneca PLC

Last Price:
$69.71
Seasonality Move:
2.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $54.1B
Cash Flow: $2.7B
Price / Cash Flow: 23.89
Annual Sales: $13.24
Price / Book: 5.28

Profitability

EPS (TTM): 2.49000
Net Income (TTM): $7.8B
Gross Margin: $43.9B
Return on Equity: 19.55%
Return on Assets: 7.44%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 27 years for AZN is 81.12%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 37.40% of Gross Profit Margin.
  • The Research & Development expenses have been 25.12% of Revenue.
  • The Interest Expense is 23.91% of Operating Income.
  • The Net Earning history of AZN is 13.01% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 21 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.72
Current Ratio: 0.9
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 31.08
Forward P/E Ratio: 13.84

AZN Technical Analysis vs Fundamental Analysis

Buy
54
AstraZeneca PLC (AZN) is a Buy

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Buy
    The current AstraZeneca PLC [AZN] share price is $69.92. The Score for AZN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.